Skip to main content
. 2013 Aug 30;8(8):e72817. doi: 10.1371/journal.pone.0072817

Table 1. Effect of concomitant administration of cycloart-23-ene-3β, 25 diol and L-glutamine with sitagliptin on body weight, food and water intake in streptozotocin – nicotinamide induced diabetic rats.

Parameters Non-diabetic Diabetic control Cycloart-23-ene-3β, 25 diol(1 mg/kg) + Sitagliptin (5 mg/kg) L-glutamine (1000 mg/kg)+Sita (5 mg/kg)
Body weight (g/day) 0 198.83±5.83 208.20±6.82 208.74±2.32 201.32±2.43
Week 1 206.83±4.57 205.00±6.73 209.19±3.65 202.87±3.76
Week 2 213.50±5.73 196.40±6.97 205.32±4.19 200.62±6.18
Week 3 223.83±5.9 190.20±9.02# 213.31±5.38* 197.75±3.38
Week 4 236.66±7.62 174.40±5.77# 212.96±6.27** 198.00±5.42
Week 5 245.00±7.60 169.00±4.78# 215.02±5.38** 197.14±2.63*
Week 6 252.33±7.27 169.20±3.99# 218.59±6.12*** 197.50±4.74*
Week 7 265.33±8.27 163.00±3.46# 219.63±4.91*** 196.83±6.43**
Week 8 284.50±5.78 160.00±3.11# 225.46±6.23*** 195.49±6.40***
Food intake (g/day) 0 16.78±0.69 26.15±0.55# 26.37±0.64 26.43±0.53
Week 1 18.31±0.57 26.66±0.42# 25.03±0.53 26.19±0.69
Week 2 18.48±0.58 28.16±0.70# 22.32±0.79 25.65±0.50
Week 3 19.84±0.97 30.50±0.62# 22.09±0.71 25.13±0.81***
Week 4 19.34±0.34 33.66±0.75# 23.93±0.83 24.07±0.71***
Week 5 19.68±0.36 34.37±0.42# 23.18±0.61 24.09±0.69***
Week 6 19.80±0.76 38.13±0.68# 23.73±0.79 23.49±0.30***
Week 7 18.50±0.64 37.16±0.60# 22.07±0.68 23.45±0.47***
Week 8 19.80±0.44 39.08±0.73# 21.17±0.49 23.05±0.61***
Water Intake ml/day) 0 21.83±0.60 69.50±2.33# 72.07±2.27 71.73±1.82
Week 1 22.50±0.49 69.83±1.95# 65.71±2.43 69.54±2.19
Week 2 22.61±0.51 71.00±1.75# 53.79±3.18 61.16±4.19**
Week 3 22.83±0.70 79.66±2.33# 47.31±2.69 49.50±3.14***
Week 4 22.33±0.61 82.33±2.37# 34.09±2.91 41.71±3.11***
Week 5 22.05±0.53 90.00±3.58# 28.93±1.79 32.20±2.38***
Week 6 21.16±0.47 103.33±2.45# 22.86±1.95 26.16±3.13***
Week 7 22.24±0.3 108.43±3.71# 22.48±2.39 25.09±2.17***
Week 8 22.37±0.58 116.43±2.04# 21.91±2.04 23.74±1.06***

Values are mean ± S.E.M., n = 6 in each group; statistical analysis by one way ANOVA followed by Post hoc Tukey’s test using Graphpad Instat software; p value #<0.001 compared to non-diabetic groups;

*

<0.05;

**

<0.01;

***

<0.001 compared to diabetic control group.